大富科技(300134.SZ):擬向新天梓採購包括大數據引擎、智能化中醫診療系統等在內的系列資產
格隆匯 8 月 17日丨大富科技(300134.SZ)公佈,公司之全資子公司深圳市大富智慧健康科技有限公司(“智慧健康公司”)為拓展智慧健康等新領域業務,為上市公司提供新的盈利增長點。
2019年9月,智慧健康公司與北京新天梓教育科技發展有限公司(“新天梓”)簽訂了《採購協議》,向北京新天梓教育科技發展有限公司採購醫療器械、健康大數據系統、智能醫療系統等相關成果及技術方案;2020年4月簽訂的《補充協議》,新天梓同意前述《採購協議》簽署後3年內,若公司採購的產品及方案收益未達到公司採購成本4950萬元,公司有權要求其進行回購,新天梓應在收到回購通知後30個工作日內予以回購。公司關聯方之得道健康管理有限公司同意對新天梓的回購義務承擔連帶保證責任。
資產清單:1、脈診儀和經絡儀及技術方案;2、中醫健康大數據系統及公眾號程序;3、大數據引擎及數據服務系統和相關技術方案;4、醫院信息管理系統(HIS系統)及技術方案;5、艾灸協作機器人及技術方案;6、智能化中醫診療系統及技術方案(包括脈診儀系統、經絡儀系統與協作機器人系統進行整合優化成整體方案)7、技術服務。雙方協商一致同意該筆無形資產交易金額為4950.00萬元。
智慧健康主營業務為健康管理諮詢、電子智能化設備的技術開發與銷售、人工智能技術與設備生產開發與應用、雲計算應用及服務等。此次智慧健康向新天梓採購包括大數據引擎、智能化中醫診療系統等在內的系列資產,有利於智慧健康平台內容、基礎數據、診療方法的豐富和完善,對公司開拓網絡設計平台的下游應用,開拓B2C的業務模式,開展智慧健康相關新業務具有重要的價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.